These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 33882988)
1. Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk. Novikova G; Andrews SJ; Renton AE; Marcora E Mol Neurodegener; 2021 Apr; 16(1):27. PubMed ID: 33882988 [TBL] [Abstract][Full Text] [Related]
2. Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Novikova G; Kapoor M; Tcw J; Abud EM; Efthymiou AG; Chen SX; Cheng H; Fullard JF; Bendl J; Liu Y; Roussos P; Björkegren JL; Liu Y; Poon WW; Hao K; Marcora E; Goate AM Nat Commun; 2021 Mar; 12(1):1610. PubMed ID: 33712570 [TBL] [Abstract][Full Text] [Related]
3. Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia. Guo S; Yang J Alzheimers Res Ther; 2024 Jun; 16(1):120. PubMed ID: 38824563 [TBL] [Abstract][Full Text] [Related]
4. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping. Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627 [TBL] [Abstract][Full Text] [Related]
5. Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion. Xiong X; James BT; Boix CA; Park YP; Galani K; Victor MB; Sun N; Hou L; Ho LL; Mantero J; Scannail AN; Dileep V; Dong W; Mathys H; Bennett DA; Tsai LH; Kellis M Cell; 2023 Sep; 186(20):4422-4437.e21. PubMed ID: 37774680 [TBL] [Abstract][Full Text] [Related]
6. Interpretation of risk loci from genome-wide association studies of Alzheimer's disease. Andrews SJ; Fulton-Howard B; Goate A Lancet Neurol; 2020 Apr; 19(4):326-335. PubMed ID: 31986256 [TBL] [Abstract][Full Text] [Related]
7. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility. Amber S; Zahid S Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757 [TBL] [Abstract][Full Text] [Related]
8. Predicting regulatory variants using a dense epigenomic mapped CNN model elucidated the molecular basis of trait-tissue associations. Pei G; Hu R; Dai Y; Manuel AM; Zhao Z; Jia P Nucleic Acids Res; 2021 Jan; 49(1):53-66. PubMed ID: 33300042 [TBL] [Abstract][Full Text] [Related]
9. Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration. Matoba N; Quiroga IY; Phanstiel DH; Won H J Vis Exp; 2020 Jan; (155):. PubMed ID: 31984958 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide significant, replicated and functional risk variants for Alzheimer's disease. Guo X; Qiu W; Garcia-Milian R; Lin X; Zhang Y; Cao Y; Tan Y; Wang Z; Shi J; Wang J; Liu D; Song L; Xu Y; Wang X; Liu N; Sun T; Zheng J; Luo J; Zhang H; Xu J; Kang L; Ma C; Wang K; Luo X J Neural Transm (Vienna); 2017 Nov; 124(11):1455-1471. PubMed ID: 28770390 [TBL] [Abstract][Full Text] [Related]
11. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms. Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853 [TBL] [Abstract][Full Text] [Related]
12. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era. Broekema RV; Bakker OB; Jonkers IH Open Biol; 2020 Jan; 10(1):190221. PubMed ID: 31937202 [TBL] [Abstract][Full Text] [Related]
14. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis. Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600 [TBL] [Abstract][Full Text] [Related]
15. An analysis of genetically regulated gene expression across multiple tissues implicates novel gene candidates in Alzheimer's disease. Gerring ZF; Lupton MK; Edey D; Gamazon ER; Derks EM Alzheimers Res Ther; 2020 Apr; 12(1):43. PubMed ID: 32299494 [TBL] [Abstract][Full Text] [Related]
16. Genomic variants, genes, and pathways of Alzheimer's disease: An overview. Naj AC; Schellenberg GD; Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):5-26. PubMed ID: 27943641 [TBL] [Abstract][Full Text] [Related]
17. Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease. Lu Q; Powles RL; Abdallah S; Ou D; Wang Q; Hu Y; Lu Y; Liu W; Li B; Mukherjee S; Crane PK; Zhao H PLoS Genet; 2017 Jul; 13(7):e1006933. PubMed ID: 28742084 [TBL] [Abstract][Full Text] [Related]
18. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks. Tansey KE; Cameron D; Hill MJ Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603 [TBL] [Abstract][Full Text] [Related]
19. Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer's disease. Liu N; Xu J; Liu H; Zhang S; Li M; Zhou Y; Qin W; Li MJ; Yu C; PLoS Genet; 2021 Feb; 17(2):e1009363. PubMed ID: 33630843 [TBL] [Abstract][Full Text] [Related]